Frédérique Nowak is currently Head of the Department of Biology, Transfer and Innovations at the Research and Innovation Directorate of the Institut National du Cancer (INCa), France.
After a master in bioengineering from the Ecole Centrale of Paris, France (1992), Frédérique Nowak started her career at the Institut Gustave Roussy, a preeminent comprehensive cancer centre located in Villejuif (south of Paris), France, where she got a PhD in Molecular Pharmacology in 1996.
After her PhD, she joined Genset, a high-profile biotechnology company, where she was project manager for innovative projects in high-throughput molecular cytogenetics.
Between 2002 and 2006, she was responsible for a R&D team at the Serono Genetics Institute of the Serono pharmaceutical company in Evry, France.
She joined INCa in 2006 as a project leader in charge of anatomopathology and molecular genetics.
F. Nowak is currently in charge of the coordination of the INCa’s personalized oncology programs and more particularly of the nationwide initiative for providing an equal access to molecular testing. She has been instrumental in the setting up of the 28 molecular genetics centers in France, organized into a national network (F Nowak and coll.; Nat. Rev. Clin. Oncol. 2012). France organizational framework represents a unique example of a nationwide implementation of personalized medicine into clinical practice and illustrates that molecular stratification can be successfully integrated into the healthcare system.